SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001461993-19-000045
Filing Date
2019-08-09
Accepted
2019-08-09 07:40:36
Documents
79
Period of Report
2019-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q mlnt-063019x10q.htm 10-Q 998353
2 EXHIBIT 31.1 mlnt-063019ex311.htm EX-31.1 14046
3 EXHIBIT 31.2 mlnt-063019ex312.htm EX-31.2 13969
4 EXHIBIT 32.1 mlnt-063019ex321.htm EX-32.1 8059
5 EXHIBIT 32.2 mlnt-063019ex322.htm EX-32.2 7855
  Complete submission text file 0001461993-19-000045.txt   7711986

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT mlnt-20190630.xml EX-101.INS 1754471
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT mlnt-20190630.xsd EX-101.SCH 57490
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT mlnt-20190630_cal.xml EX-101.CAL 92262
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT mlnt-20190630_def.xml EX-101.DEF 352623
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT mlnt-20190630_lab.xml EX-101.LAB 733853
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT mlnt-20190630_pre.xml EX-101.PRE 503744
Mailing Address 44 WHIPPANY ROAD MORRISTOWN NJ 07963
Business Address 44 WHIPPANY ROAD MORRISTOWN NJ 07963 908 617-1309
MELINTA THERAPEUTICS, INC. /NEW/ (Filer) CIK: 0001461993 (see all company filings)

IRS No.: 454440364 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35405 | Film No.: 191011322
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences